Cocrystal Pharma (COCP) Revenue (2010 - 2026)
Cocrystal Pharma (COCP) posted Revenue of $225000.0 for Q1 2026, down 55.88% sequentially from $510000.0 in Q4 2020.
Cocrystal Pharma (COCP) Revenue (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Revenue for 8 years, with the latest figure at $225000.0 in Q1 2026.
- Quarterly Revenue changed N/A year-over-year to $225000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (changed N/A YoY) and the FY2020 annual result came in at $2.0 million, down 69.32% from the prior year.
- Revenue declined to $225000.0 in Q1 2026 per COCP's latest filing, from $510000.0 in the prior quarter.
- Over five years, Revenue peaked at $225000.0 in Q1 2026 and troughed at $225000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | 105,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105,000.00 |
| Mar 31, 2026 | 225,000.00 |
| Dec 31, 2020 | 510,000.00 |
| Sep 30, 2020 | 489,000.00 |
| Jun 30, 2020 | 554,000.00 |
| Mar 31, 2020 | 461,000.00 |
| Dec 31, 2019 | 402,000.00 |
| Sep 30, 2019 | 492,000.00 |
| Jun 30, 2019 | 592,000.00 |
| Mar 31, 2019 | 5.08 Mn |
| Sep 30, 2015 | 24,000.00 |
| Jun 30, 2015 | 27,000.00 |
| Mar 31, 2015 | 27,000.00 |
| Jun 30, 2013 | 1.96 Mn |
| Mar 31, 2013 | 2.03 Mn |
| Dec 31, 2012 | 3.87 Mn |
| Sep 30, 2012 | 4.89 Mn |
| Jun 30, 2012 | 4.91 Mn |
| Mar 31, 2012 | 3.51 Mn |
| Dec 31, 2011 | 3.67 Mn |